Bio-Techne Corp at Goldman Sachs Global Healthcare Conference Transcript
We can get started. Thanks for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Goldman. Happy to have Chuck and Jim, the CEO and CFO from Bio-Techne, here with us today. It's open Q&A, so feel free if you have any questions. Just raise your hands, I'll call out -- call you out.
Questions & Answers
But Chuck, maybe just to start, I'll open it up to you just to kind of talk through the most recent results. Obviously, encouraging recovery from ACD, which you guys projected. But yes, maybe just recap the most recent results and we can dive in from there.
Sure. It was a great quarter, our best quarter, I guess, in the 6 years I've been there. So we did 14-plus percent organic growth. Long time coming. We've been tracking from 0 up to the -- this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
